NCT05880576
The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the Aorta
Enrolling by Invitation
Not specifiedAges 0–60ObservationalBoston Children's HospitalInvestigator-initiated
~60 participants
Updated 2026-06-29 on ClinicalTrials.gov
What's tested:Monitoring using resonance Raman spectroscopy, pulse oximetry, blood pressure, and near-infrared spectroscopy
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants with arch or CoA repair
Measured over First 3 postnatal months
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Study leadership
- John Kheir, MD · PRINCIPAL_INVESTIGATOR · Boston Children's Hospital
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Infants with echocardiography-based possible or definite aortic arch obstruction and \<1 month postnatal age admitted to the CICU
Exclusion
Known carrier status for resistant organisms. Resistant organisms are defined as MRSA and VRE.
What this trial measures
- Number of participants with arch or CoA repairFirst 3 postnatal months
Surgical or catheter-based repair of the aortic arch or coarctation of the aorta